Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 600 results

research Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?

10 citations , March 2016 in “The Journal of Obstetrics and Gynecology of India”

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

research Diagnosis of Polycystic Ovary Syndrome

97 citations , February 2007 in “Clinical Obstetrics and Gynecology”

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations , August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

research Sex Hormone-Binding Globulin as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome

58 citations , November 2020 in “International Journal of Molecular Sciences”

SHBG may be a useful early indicator and treatment target for PCOS.

research Tumor Necrosis Factor-Alpha and Polycystic Ovarian Syndrome: A Clinical, Biochemical, and Molecular Genetic Study

26 citations , August 2014 in “Genetic Testing and Molecular Biomarkers”

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

View more "aes 2006" in research →

Community Join

5 / 9 results

community It seems that topical Minoxidil can also cause pericardial effusion after all

in General 92 upvotes 3 weeks ago

Topical Minoxidil may cause pericardial effusion. Caution is advised when using Minoxidil, even topically.

community How much oral minoxidil is satisfactory?

in Minoxidil 6 upvotes 1 year ago

A user taking 1.25mg finasteride and 2.5mg oral minoxidil for hair loss, questioning if the dosage is enough for scalp hair regrowth. Another user reassures that hair will regrow stronger after initial shedding.

community A new meta-analysis of 23 studies has confirmed that 5 milligrams a day of oral dutasteride had the highest probability of reducing male hair loss, followed by 5 milligrams a day of oral finasteride, followed by 5 milligrams of oral minoxidil, followed by 1 milligram a day of oral finasteride

in Research/Science 82 upvotes 3 years ago

Oral dutasteride (0.5mg) is most effective for male hair loss, followed by oral finasteride (5mg), oral minoxidil (5mg), and oral finasteride (1mg). Different treatments have benefits and side effects, and results don't apply to women's hair loss.

community 1 year fin 1mg and minox. can see some density reclaimed

in Update 562 upvotes 4 years ago

User shared 1-year progress using finasteride 1mg and minoxidil, regaining hair density. Others praised the improvement and asked about side effects and additional treatments.

community The Placebo Group Has It Worse Than The Standard Prescription 0.5mg Group. -The fear is all in your head.

in Finasteride/Dutasteride 191 upvotes 4 weeks ago

Dutasteride at 0.5mg may have fewer sexual side effects than expected, with many side effects attributed to psychological factors (nocebo effect). The placebo group experienced more side effects, suggesting fear and anxiety might contribute to perceived side effects.

View more "aes 2006" in community →